Physician
Nephrology
Dr. Hideki Kawanishi, MD
|
|
Give Review
Hideki Kawanishi is an expert in the field of Nephrology. He attended Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74 in research and 67 in primary care medicine He has 1 awards "CMS Meaningful Use Stage 1 Certification". Hideki Kawanishi is also published. He has 85 publications published. The lastest publication: "[Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients...' He is registered with Medicare and accepts Medicare payments.
Publications
- [Cooperation between primary care physicians and nephrologists (the current status and the future of nephrologists, including a comparison between Japan and the United...
- [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal Failure--comparison between patients with chronic glomerulonephritis and patients...
- The gastrointestinal Manifestations of gunshot-induced lead poisoning.
- Na(+)-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on t...
- A utility of ductography and fiberoptic ductoscopy for patients With nipple discharge.
- Statistical analysis of diagnostic Failure of fine needle aspiration cytology (FNAC) in breast cancer.
- [Continuous monitoring of blood volume change by measuring hematocrit during cardiopulmonary bypass].
- Precise ultrastructural localization of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in patients...
- Heat shock cellular stress on aged gut-associated lymphocytes; mRNA expression of inducible heat shock protein gene and protooncogenes.
- The pathogenesis and therapeutic option of encapsulating peritoneal sclerosis.
- Complementary use of peritoneal and hemodialysis: therapeutic synergies in the treatment of end-stage renal Failure patients.
- [Intra-operative management during laparotomy for patients under hemodialysis].
- Relationship between erythropoietin and chronic heart Failure in patients on chronic hemodialysis.
- Direct infusion of ascites into the blood circuit during hemodiafiltration in uremic patients With cirrhosis.
- Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Managem...
- Lanthanum carbonate treatment of patients With hyperphosphatemia undergoing CAPD.
- Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal Disease.
- Necessity of correcting cancer antigen 125 appearance rates by body surface area.
- Encapsulating peritoneal sclerosis in Japan: prospective multicenter controlled study.
- Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.
- Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration M...
- Surgical treatment for sclerosing encapsulating peritonitis.
- Hemodialysis together With peritoneal dialysis is one of the simplest ways to maintain adequacy in continuous ambulatory peritoneal dialysis.
- Treatment options for encapsulating peritoneal sclerosis based on progressive stage.
- Icodextrin and intraperitoneal inflammation.
- A role for the Asian peritoneal dialysis community in Renal replacement therapy worldwide.
- Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis.
- Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-Calcium dialysate in patients on continuous ambulatory peritoneal di...
- Complementary dialysis for daily dialysis.
- Kinetics and dose of daily hemofiltration.
- Clinical results of daily hemofiltration.
- Seventeen years'' experience of surgical options for encapsulating peritoneal sclerosis.
- Preferred performance of the high-performance membrane in the case of online hemodiafiltration.
- Effects of raloxifene on bone mineral Metabolism in postmenopausal Japanese women on hemodialysis.
- Prospective multicenter observational study of encapsulating peritoneal sclerosis With neutral dialysis solution--the NEXT-PD study.
- Impact of combination therapy With peritoneal dialysis and hemodialysis on peritoneal function.
- Fully automated dialysis system for online hemodiafiltration built into the central dialysis fluid delivery system.
- Terminology and classification of blood purification in critical care in Japan.
- No need for an "expiry date" in Chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world.
- Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD.
- A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritoneal solution.
- Peritoneal dialysis patients With high effluent fibrin degradation products.
- Fully automated dialysis system based on the central dialysis fluid delivery system.
- Guidance of technical management of dialysis water and dialysis fluid for the Japan Association for Clinical Engineering Technologists.
- The new standard of fluids for hemodialysis in Japan.
- Current status and perspective of the dialysis fluid delivery system in relation to dialysis fluid purification. Preface.
- Kinetic analysis of daily hemofiltration.
- Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008.
- Encapsulating peritoneal sclerosis--medical and surgical treatment.
- Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis.
- Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis.
- Plasma S100A12 concentrations in peritoneal dialysis patients and subclinical Chronic inflammatory disease.
- Evaluation of dialysis dose during combination therapy With peritoneal dialysis and hemodialysis.
- Encapsulating peritoneal sclerosis: prevention and treatment.
- Clinical effects of combined therapy With peritoneal dialysis and hemodialysis.
- On-line continuous hemodiafiltration in sepsis.
- Experience of 100 surgical cases of encapsulating peritoneal sclerosis: investigation of recurrent cases after surgery.
- Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
- Early estimation of high peritoneal permeability can predict poor prognosis for technique survival in patients on peritoneal dialysis.
- Guideline on targets for solute and fluid removal in adult patients on Chronic peritoneal dialysis.
- Markers in peritoneal effluent for Withdrawal from peritoneal dialysis: multicenter prospective study in Japan.
- Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane.
- Combination therapy With peritoneal dialysis and hemodialysis.
- Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures.
- Successful surgical management of encapsulating peritoneal sclerosis.
- Epidemiology of encapsulating peritoneal sclerosis in Japan.
- Correlation between peritoneal permeability and ultrafiltration volume With icodextrin-based peritoneal dialysis solution.
- Dialysis dose and nutrition in Japanese peritoneal dialysis patients.
- Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.
- [QOL and self-care for dialysis patients].
- [Nutritional management in EN and TPN for dialysis patients].
- Encapsulating peritoneal sclerosis-like findings in a hemodialysis patient Without a history of peritoneal dialysis.
- Questionnaire to peritoneal dialysis patients undergoing combined therapy (peritoneal dialysis and hemodialysis).
- Re-evaluation of adequate dose in Japanese peritoneal dialysis patients.
- Experience With the JMS fully automated dialysis machine.
- Effect of Diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD.
- Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis.
- Surgical treatment for encapsulating peritoneal sclerosis.
- Influence of pH-neutral peritoneal dialysis solution.
- Five years'' experience of combination therapy: peritoneal dialysis With hemodialysis.
- Type B lactic Acidosis: a rare complication of antiretroviral therapy after cardiac surgery.
- On-line hemodiafiltration in critical care.
- Induction of IgA B cell differentiation of bone marrow-derived B cells by Peyer's patch autoreactive helper T cells.
- Chronic hepatitis B infection and autoimmune thyroiditis in Down syndrome.
Schools
UmdnjRobert Wood Johnson Medical School
UMDNJ R W Johnson Med School
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UMDNJ-Robert Wood Johnson Medical School -
Rutgers Robert Wood Johnson Medical School
Drug Facts
| NPI NUMBER | 1376657783 | |
| NPPES Provider LastName | KAWANISHI | |
| NPPES Provider FirstName | HIDEKI | |
| NPPES Provider ZIPCode | 474015524 | |
| NPPES Provider State | IN | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1850.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1376657783 |
| Last Name Of The Provider | KAWANISHI |
| First Name Of The Provider | HIDEKI |
| View All |
Similar Doctors
|
|
Dr. Theresa A. Travis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank K. Boateng, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard C. Combs, MD
This Doctor is OpenDoctor Recommended.
|